Friday, December 3, 2021
ad
Home News Associations CRN Unveils New Membership Plan for 2022

CRN Unveils New Membership Plan for 2022

The Council for Responsible Nutrition (CRN), the top enterprise association for the dietary supplement and functional food industry, announced a new membership dues plan for 2022. The plan will reduce the yearly dues for numerous companies. As a result, CRN membership will be available to companies of all sizes. Additionally, the plan addresses the continuous industry consolidation and gives an equitable rate structure that will allow CRN to continue tackling the wide range of issues vital to the industry’s future.

“This change opens the playing field to more companies,” said CRN Chairman Barry Ritz, Ph.D., Vice President of Science, Regulatory, and Innovation at Nestle Health Science. “Midsize companies that previously perceived us as ‘too expensive’ now have the opportunity to secure a seat at the CRN table,” he added.

The shift in dues structure was recommended by a task force of CRN members chosen by Ritz and unanimously approved by the CRN Board of Directors in June 2021. The new rate schedule means that numerous companies will see a reduction in their annual dues, especially organizations with $50-$400 million in annual sales. Nevertheless, firms with more than $400 million yearly sales will see dues increase, with any substantial changes phased over in three years.

“CRN members recognize the return on their investment in membership is unmatched in this industry,” explained Steve Mister, CRN’s president & CEO. “The evolution in our dues structure ensures CRN can continue to provide our members with the industry leadership, government engagement, and experienced counsel they rely on,” he added.

ad
- Advertisment -

Most Popular

Gadot Biochemicals Announces Mineral Fortification Program for Plant-based Milk

Israel-based Gadot Biochemical Industries (GBI), a leading global dietary mineral supplier, has unveiled a new focus on plant-based milk fortification with its...

New Study Highlights Vit K2 Potential Combination for CKD Patients

A newly published animal model, supported by NattoPharma, shows the potential of inhibiting vascular calcification when combining Vitamin K2 with phosphate binders.

Nutrasource Joins NASC as Preferred Supplier

Nutrasource Pharmaceutical and Nutraceutical Services, a global full-service contract research organization (CRO), recently announced its membership into the NASC (National Animal Supplement...

Farlong Pharmaceutical Announces Three-Year Clinical Trial Determining the Effect of Farlong NotoGinseng™

Farlong Pharmaceutical, a vertically integrated, plant-based ingredient and supplement company, recently announced the publication of the results of their clinical trial titled “Randomized,...

Subscribe to our newsletter

To be updated with all the latest news, offers and special announcements.

- Advertisment -